The cologne stroke experience:: Safety and outcome in 450 patients treated with intravenous thrombolysis

被引:47
|
作者
Sobesky, Jan
Frackowiak, Monika
Weber, Olivier Zaro
Hahn, Moritz
Moeller-Hartmann, Walter
Rudolf, Jobst
Neveling, Michael
Grond, Martin
Schmulling, Susanne
Jacobs, Andreas
Heiss, Wolf-Dieter
机构
[1] Univ Cologne, Dept Neurol, Max Planck Inst Neurol Res, D-50924 Cologne, Germany
[2] Univ Cologne, Dept Diagnost Radiol, Cologne, Germany
[3] Univ Cologne, Dept Med Stat, Cologne, Germany
关键词
intravenous thrombolysis; modified Rankin scale; functional independence; stroke;
D O I
10.1159/000103117
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Predictors of outcome and safety in intravenous thrombolysis within 3 h in clinical routine is a matter of ongoing debate. Available reports contain small patient numbers or summarize heterogeneous multicenter data. Methods: Four hundred and fifty patients received intravenous thrombolysis within 3 h after stroke. Pretreatment NIHSS score and detailed medical history were analyzed. Noncontrast CT was performed before thrombolysis, 24-36 h later and in case of clinical deterioration. Symptomatic intracranial hemorrhage (SICH; any bleeding with an NIHSS increase of >= 4 points) and clinical outcome (modified Rankin Scale, mRS) after 3 months were recorded. Logistic regression identified parameters predictive of independence (mRS 0 - 2) and SICH. Results: Median onset to admission, door to needle and onset to treatment time was 75, 50 and 135 min, respectively. Direct presentation by emergency service (64%) was the fastest way of referral. Median pretreatment NIHSS was 11 points. Independence (mRS 0-2) was reached by 53%. Mortality was 11% (7% intracerebral, 4% extracerebral complications). Logistic regression identified low NIHSS, low age and absent diabetes as predictors of independence. Overall hemorrhagic complications and SICH were found in 18 and 4% of the patients, respectively. Extracerebral bleeding complications and allergic reactions were found in 3 and 1%, respectively. Conclusion: This largest single center report presents a sample in the range of the 3 h rt-PA cohort of all randomized controlled trials. Outcome was comparable to randomized studies with a higher rate of independence and a lower rate of mortality and SICH. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 50 条
  • [1] The cologne stroke experience: Safety and outcome data in 500 patients treated by IV thrombolysis
    Sobesky, Jan
    Frackowiak, Monika
    Zaro-Weber, Olivier
    Moeller-Hartmann, Walter
    Dohmen, Christian
    Neveling, Michael
    Rudolf, Jobst
    Grond, Martin
    Heiss, Wolf D.
    [J]. STROKE, 2007, 38 (02) : 511 - 511
  • [2] Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients Treated with Warfarin
    Mazya, Michael V.
    Lees, Kennedy R.
    Markus, Romesh
    Roine, Risto O.
    Seet, Raymond C. S.
    Wahlgren, Nils
    Ahmed, Niaz
    [J]. ANNALS OF NEUROLOGY, 2013, 74 (02) : 266 - 274
  • [3] Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis
    Aulicky, P.
    Mikulik, R.
    Goldemund, D.
    Reif, M.
    Dufek, M.
    Kubelka, T.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (07): : 783 - 787
  • [4] Safety of intravenous thrombolysis for acute ischemic stroke in patients treated with warfarin
    Mazya, M. V.
    Lees, K. R.
    Markus, R.
    Roine, R.
    Seet, R. C. S.
    Wahlgren, N.
    Ahmed, N.
    [J]. CEREBROVASCULAR DISEASES, 2013, 35 : 567 - 567
  • [5] Clinical outcome of cardioembolic stroke treated by intravenous thrombolysis
    Vaclavik, D.
    Vilionskis, A.
    Jatuzis, D.
    Karlinski, M. A.
    Gdovinova, Z.
    Korv, J.
    Tsivgoulis, G.
    Mikulik, R.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2018, 137 (03): : 347 - 355
  • [6] Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis
    Sanak, D.
    Herzig, R.
    Zapletalova, J.
    Horak, D.
    Kral, M.
    Skoloudik, D.
    Bartkova, A.
    Veverka, T.
    Herman, M.
    Kanovsky, P.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2011, 123 (05): : 339 - 344
  • [7] Temporal Trends of Functional Outcome in Acute Stroke Patients Treated with Intravenous Thrombolysis
    Marko, M.
    Miksova, D.
    Langer, A.
    Ebner, J.
    Sommer, P.
    Serles, W.
    Knoflach, M.
    Lang, W.
    Kiechl, S.
    Greisenegger, S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 218 - 218
  • [8] Impact of body mass index on outcome in stroke patients treated with intravenous thrombolysis
    Gensicke, H.
    Wicht, A.
    Bill, O.
    Zini, A.
    Costa, P.
    Kagi, G.
    Stark, R.
    Seiffge, D. J.
    Traenka, C.
    Peters, N.
    Bonati, L. H.
    Giovannini, G.
    De Marchis, G. M.
    Poli, L.
    Polymeris, A.
    Vanacker, P.
    Sarikaya, H.
    Lyrer, P. A.
    Pezzini, A.
    Vandelli, L.
    Michel, P.
    Engelter, S. T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (12) : 1705 - 1712
  • [9] Effect of haemoglobin levels on outcome in intravenous thrombolysis-treated stroke patients
    Altersberger, Valerian L.
    Kellert, Lars
    Al Sultan, Abdulaziz S.
    Martinez-Majander, Nicolas
    Hametner, Christian
    Eskandari, Ashraf
    Heldner, Mirjam R.
    van den Berg, Sophie A.
    Zini, Andrea
    Padjen, Visnja
    Kaegi, Georg
    Pezzini, Alessandro
    Polymeris, Alexandros
    DeMarchis, Gian M.
    Tiainen, Marjaana
    Raty, Silja
    Nannoni, Stefania
    Jung, Simon
    Zonneveld, Thomas P.
    Maffei, Stefania
    Bonati, Leo
    Lyrer, Philippe
    Sibolt, Gerli
    Ringleb, Peter A.
    Arnold, Marcel
    Michel, Patrik
    Curtze, Sami
    Nederkoorn, Paul J.
    Engelter, Stefan T.
    Gensicke, Henrik
    [J]. EUROPEAN STROKE JOURNAL, 2020, 5 (02) : 138 - 147
  • [10] Admission Hyperglycemia Predicts a Worse Outcome in Stroke Patients Treated With Intravenous Thrombolysis
    Poppe, Alexandre Y.
    Majumdar, Sumit R.
    Jeerakathil, Thomas
    Ghali, William
    Buchan, Alastair M.
    Hill, Michael D.
    [J]. DIABETES CARE, 2009, 32 (04) : 617 - 622